[VIEW] agent=Supply Chain Contracting Director | scenario_id=112 | rounds=20

--- Round 0 ---
[R0.1] Infection Prevention & Control (IPC) Director (speak, public): To create a robust remediation plan, we need to assess our current cleaning performance and understand any operational challenges. Can we discuss the cleaning effectiveness audits and any potential staffing or resource constraints in your departments?
[R0.2] Environmental Services (EVS) Operations Manager (speak, public): I agree that understanding our cleaning performance is crucial. Currently, we have a median terminal clean cycle time of 62 minutes per discharge, and our disinfectant dwell-time adherence is at 54% compliance on recent audits. Additionally, the ATP pass rate from high-touch surface testing stands at 76%. With these metrics in mind, we need to consider how we can improve our operational efficiency and address any resource constraints. What specific infection-control outcomes are we targeting?
[R0.3] Supply Chain Contracting Director (speak, private to=Infection Prevention & Control (IPC) Director,Environmental Services (EVS) Operations Manager): To effectively target specific infection-control outcomes, could you clarify which areas of cleaning performance you'd like us to prioritize? Additionally, what are your thoughts on the potential need for sporicidal disinfectants to enhance our cleaning protocols?

--- Round 1 ---
[R1.1] Infection Prevention & Control (IPC) Director (speak, public): To achieve our target CDI rate of 6.0 per 10,000 patient-days, we need to focus on improving our cleaning effectiveness, particularly in high-risk areas like oncology. I believe that enhancing our compliance with disinfectant dwell-times and considering the use of sporicidal disinfectants could be vital. What are your thoughts on implementing these changes and any potential challenges you foresee?
[R1.2] Environmental Services (EVS) Operations Manager (speak, public): I appreciate your insights on targeting specific infection-control outcomes, particularly in high-risk areas like oncology. Improving our compliance with disinfectant dwell-times is certainly a priority. Regarding sporicidal disinfectants, we need to consider the procurement implications and whether our supply chain can handle the transition efficiently. Can we discuss the potential budget impact and supply reliability of switching to these products?
[R1.3] Supply Chain Contracting Director (speak, public): Switching to sporicidal disinfectants will increase our monthly spend by $28,000, but it may be necessary to enhance our cleaning effectiveness, especially in high-risk areas like oncology. We should also discuss the supplier capacity and lead time to ensure that we can handle the transition efficiently. What are your thoughts on how we can balance these costs with the required operational improvements?

--- Round 2 ---
[R2.1] Infection Prevention & Control (IPC) Director (speak, private to=Environmental Services (EVS) Operations Manager,Supply Chain Contracting Director): I understand the financial implications of switching to sporicidal disinfectants. However, considering the current CDI rate and our compliance challenges, it might be necessary to prioritize patient safety and infection control over budget constraints. Can we explore potential budget adjustments or alternative funding sources to support this transition? Additionally, how can we ensure the supply chain's reliability during this change?
[R2.2] Environmental Services (EVS) Operations Manager (speak, private to=Infection Prevention & Control (IPC) Director,Supply Chain Contracting Director): I understand the need to prioritize patient safety, and I'm open to discussing budget adjustments to facilitate the transition to sporicidal disinfectants. However, we also need to ensure that our supply chain can support this change without delays. Can we set criteria for evaluating supplier reliability and lead times, as well as discuss how we can effectively train our staff on the new products?
[R2.3] Supply Chain Contracting Director (speak, private to=Infection Prevention & Control (IPC) Director,Environmental Services (EVS) Operations Manager): I appreciate the considerations regarding budget adjustments and supply chain reliability. To ensure a smooth transition to sporicidal disinfectants, we need to establish clear criteria for evaluating suppliers, including their past performance and capacity to meet our needs. Additionally, we should develop a comprehensive training plan for our staff to ensure they are well-equipped to handle the new products. Let's collaborate on drafting these criteria and training outlines as we move forward.

--- Round 3 ---
[R3.1] Infection Prevention & Control (IPC) Director (speak, private to=Environmental Services (EVS) Operations Manager,Supply Chain Contracting Director): I appreciate the collaborative approach towards implementing sporicidal disinfectants. Let's ensure we prioritize establishing supplier criteria and developing a robust training plan for our staff. Can we set a timeline for these discussions to ensure we stay on track with our remediation plan?
[R3.2] Environmental Services (EVS) Operations Manager (speak, private to=Infection Prevention & Control (IPC) Director,Supply Chain Contracting Director): I agree that establishing a clear timeline for our discussions on supplier criteria and training plans is essential. How about we aim to finalize our criteria and training outline within the next two weeks? This will help us stay on track with the remediation plan and ensure that we are ready for the transition to sporicidal disinfectants.
[R3.3] Supply Chain Contracting Director (speak, private to=Infection Prevention & Control (IPC) Director,Environmental Services (EVS) Operations Manager): I agree with the proposed timeline of finalizing our supplier criteria and training outline within the next two weeks. This will ensure we stay on track with the remediation plan. Let's also consider scheduling a follow-up meeting to review our progress and any potential challenges we encounter during the transition.

--- Round 4 ---
[R4.1] Infection Prevention & Control (IPC) Director (speak, private to=Environmental Services (EVS) Operations Manager,Supply Chain Contracting Director): I appreciate your commitment to finalizing the supplier criteria and training outline within the next two weeks. Let's ensure we have a plan in place to assess our progress in the follow-up meeting, addressing any challenges that arise during the transition. Thank you both for your collaboration on this critical initiative.
[R4.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R4.3] Supply Chain Contracting Director (leave, public): 

--- Round 5 ---
[R5.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R5.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R5.3] Supply Chain Contracting Director (leave, public): 

--- Round 6 ---
[R6.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R6.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R6.3] Supply Chain Contracting Director (leave, public): 

--- Round 7 ---
[R7.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R7.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R7.3] Supply Chain Contracting Director (leave, public): 

--- Round 8 ---
[R8.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R8.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R8.3] Supply Chain Contracting Director (leave, public): 

--- Round 9 ---
[R9.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R9.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R9.3] Supply Chain Contracting Director (leave, public): 

--- Round 10 ---
[R10.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R10.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R10.3] Supply Chain Contracting Director (leave, public): 

--- Round 11 ---
[R11.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R11.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R11.3] Supply Chain Contracting Director (leave, public): 

--- Round 12 ---
[R12.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R12.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R12.3] Supply Chain Contracting Director (leave, public): 

--- Round 13 ---
[R13.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R13.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R13.3] Supply Chain Contracting Director (leave, public): 

--- Round 14 ---
[R14.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R14.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R14.3] Supply Chain Contracting Director (leave, public): 

--- Round 15 ---
[R15.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R15.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R15.3] Supply Chain Contracting Director (leave, public): 

--- Round 16 ---
[R16.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R16.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R16.3] Supply Chain Contracting Director (leave, public): 

--- Round 17 ---
[R17.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R17.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R17.3] Supply Chain Contracting Director (leave, public): 

--- Round 18 ---
[R18.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R18.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R18.3] Supply Chain Contracting Director (leave, public): 

--- Round 19 ---
[R19.1] Infection Prevention & Control (IPC) Director (leave, public): 
[R19.2] Environmental Services (EVS) Operations Manager (leave, public): 
[R19.3] Supply Chain Contracting Director (leave, public): 

